Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Posttransplant lymphoproliferative disorder.
Everly MJ, Bloom RD, Tsai DE, Trofe J. Everly MJ, et al. Ann Pharmacother. 2007 Nov;41(11):1850-8. doi: 10.1345/aph.1G706. Epub 2007 Oct 16. Ann Pharmacother. 2007. PMID: 17940127 Review.
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Tevar A, Woodle ES. Everly MJ, et al. Among authors: everly jj. Transplantation. 2008 Dec 27;86(12):1754-61. doi: 10.1097/TP.0b013e318190af83. Transplantation. 2008. PMID: 19104417
Proteasome inhibition reduces donor-specific antibody levels.
Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Brown E, Tevar A, Woodle ES. Everly MJ, et al. Among authors: everly jj. Transplant Proc. 2009 Jan-Feb;41(1):105-7. doi: 10.1016/j.transproceed.2008.10.073. Transplant Proc. 2009. PMID: 19249489
The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation.
Karpen SR, Klein A, Alloway RR, Albrecht R, Belen O, Campbell M, Kluetz P, Minasian LM, Mitchell SA, O'Doherty I, Papadopoulos E, Sapir-Pichhadze R, Spear N, van Gelder T, Velidedeoglu E, Page CA, Everly MJ. Karpen SR, et al. Among authors: everly mj. Transplantation. 2021 May 1;105(5):941-944. doi: 10.1097/TP.0000000000003556. Transplantation. 2021. PMID: 33901129 No abstract available.
Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD. Trivedi HL, et al. Among authors: everly mj. Transplantation. 2009 May 27;87(10):1555-61. doi: 10.1097/TP.0b013e3181a4b91b. Transplantation. 2009. PMID: 19461494
Antibody-mediated rejection despite inhibition of terminal complement.
Bentall A, Tyan DB, Sequeira F, Everly MJ, Gandhi MJ, Cornell LD, Li H, Henderson NA, Raghavaiah S, Winters JL, Dean PG, Stegall MD. Bentall A, et al. Among authors: everly mj. Transpl Int. 2014 Dec;27(12):1235-43. doi: 10.1111/tri.12396. Epub 2014 Aug 20. Transpl Int. 2014. PMID: 24990476 Free article. Clinical Trial.
87 results